Genmab A/S (NASDAQ:GMAB) Research Coverage Started at Cowen

Cowen took over coverage of shares from Genmab A/S (NASDAQ:GMAB – Get Rating) in a report published Monday, Briefing.com reports. The company assigned a market perform rating and a price target of $38.00 on the stock. Cowen’s price target indicates a potential upside of 8.02% from the company’s current price. Several other analysts have also … اقرأ المزيد

Barrington Research Equities Analysts Decrease Earnings Estimates for LeMaitre Vascular, Inc. (NASDAQ:LMAT)

LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Rating) – Analysts at Barrington Research lowered their Q2 2022 EPS estimates for LeMaitre Vascular shares in a report published on Friday, April 29. Barrington Research analyst M. Petusky now expects the medical instrument maker to report earnings of $0.31 per share for the quarter, down from his previous … اقرأ المزيد